Medtech GTM · commercialisation · launch
Medtech go-to-market strategy
A medtech go-to-market strategy turns a cleared device into revenue: which market first, which providers, which buying roles, what evidence and which channels.
Medtech commercialisation fails less often on the device than on the order of work: launching broadly before one segment is won.
GTM Quest is a medtech marketing agency that starts the motion on day one and builds the system around it in weeks 1 to 4.
Reviewed by GTM Quest · 27 October 2026 · 8 sources linked below
How a medtech launch runsone segment first
- 01Market orderBEFORE LAUNCHCLEARANCE · ACCESS
- 02Beachhead segmentWEEKS 1 TO 2PROVIDERS · PROCEDURES
- 03Committee and evidenceWEEKS 2 TO 4ROLES · ASSETS
- 04Launch and learnMONTHS 2 TO 3ACCOUNTS · SALES
What comes firstOne segment
01/ the strategy
What is a medtech go-to-market strategy? six parts of one plan
Medtech GTM covers everything between regulatory clearance and repeatable sales.
Module 01 / 06
Market order
Which country or region to launch in first, based on where the device can be sold and where the evidence is strongest.
Module 02 / 06
Beachhead segment
The providers, procedures and care settings where the device has the clearest advantage.
Module 03 / 06
Buying committee
The clinical, procurement, finance and technical roles who shape each decision.
Module 04 / 06
Evidence plan
The approved evidence each role needs, and the gaps your clinical team must close.
Module 05 / 06
Channels
Field sales, distributors, conferences, account-based campaigns and procurement routes.
Module 06 / 06
Measures
Coverage of target accounts, evaluations started and opportunities progressing, reviewed every week.
A medtech go-to-market strategy has six parts: market order, segment, buying committee, evidence, channels and measures.
02/ market order
Which market should a device launch in first? what the regulators say
Market order starts with where the device can legally be sold; your regulatory team owns that answer.
The pathway decides timing and claims; the go-to-market strategy decides who hears them and in what order.
03/ segment
How do you choose the beachhead segment? five tests for each candidate
Module 01 / 05
Clear advantage
The device solves a problem these providers feel now, better than what they already use.
Module 02 / 05
Evidence fit
You already hold approved evidence that answers this segment's clinical question.
Module 03 / 05
Reachable committee
You can name the roles and reach them through sales, events or campaigns.
Module 04 / 05
Buying route
There is a procurement route the provider can actually use this year.
Module 05 / 05
Reference value
A win here makes the next segment easier, because peers watch these providers.
Our guide to medtech target account selection turns these tests into a scored account list.
A segment that passes all five tests is worth winning before any second segment is opened.
04/ order of work
The medical device go-to-market strategy, in order six steps from clearance to revenue
- 01
Confirm the market order
Agree with your regulatory team where and when the device can be sold.
Step 1 - 02
Pick the beachhead
Choose one segment using the five tests, and write down why.
Step 2 - 03
Map the committee
Name the clinical, procurement, finance and technical roles at each target account.
Step 3 - 04
Build the evidence matrix
Match each role to an approved asset, owner and review status.
Step 4 - 05
Launch to named accounts
Start the motion on day one with sales, events and account-based campaigns.
Step 5 - 06
Review weekly
Track coverage, evaluations and opportunities, and adjust the segment before scaling.
Step 6
For step 3, our hospital buying committee mapping guide shows how to record each role.
For step 5, see account-based marketing for medtech.
The medical device marketing strategy guide goes deeper on steps 3 to 5.
05/ UK route
How does a device reach the NHS? the procurement side of medtech GTM
In England, NHS Supply Chain says it works with NHS England, NICE and the Health Innovation Network to introduce new technologies into the NHS.
Module 01 / 04
Evidence standards
Digital health technologies can be assessed against the NICE evidence standards framework, which NICE updated in 2022 to include AI and data-driven technologies.
Module 02 / 04
Innovation route
NHS Supply Chain describes its role as the final step in bringing innovative products to market through a legally compliant procurement route (source).
Module 03 / 04
Procurement rules
NHS Supply Chain notes that the Procurement Act 2023 became effective from 24 February 2025.
Module 04 / 04
Local adoption
A framework listing is not a sale; each trust's committee still decides, so account work continues after the listing.
NHS Supply Chain says the Procurement Act moves tender evaluation from the Most Economically Advantageous Tender to the Most Advantageous Tender (source).
Our guide to selling to the NHS sets out the supplier side step by step.
06/ routes
Direct sales or distributors? two routes to the provider
Pick a comparison.
→ Many suppliers sell direct in the beachhead and use distributors to extend; either way, the account plan stays yours.
→ Win one segment, then use it as the reference for the next.
07/ the field
Why focus beats breadth in medtech commercialisation a crowded field of small suppliers
There are more than 36,000 medical technology companies in Europe, according to MedTech Europe's 2025 figures.
Module 01 / 04
Crowded categories
Buyers see many similar claims, so a message aimed at everyone is remembered by no one.
Module 02 / 04
Small teams
Small and medium-sized companies make up around 90% of the European industry, per MedTech Europe, so most suppliers cannot cover every segment.
Module 03 / 04
Long cycles
Committee decisions take time, so coverage of fewer accounts outlasts thin coverage of many.
Module 04 / 04
Reference effect
Providers watch their peers; a won segment makes the next one easier.
Most device suppliers are small, so a medtech go-to-market strategy should spend effort where one segment can be won.
08/ next step
Where are you now? pick your stage
What stage is the device at?
Plan
Build the plan in parallel
Use the runway to pick the segment, map committees and plan evidence, so launch day starts with named accounts.
Launch
Launch to one segment
Run the beachhead with a B2B marketing agency for medtech that starts on day one.
Accounts
Fix the committee coverage
A medtech ABM agency can map the committee and match evidence to each role.
15 minutes · video or phone
Book 15 minutes on your medtech go-to-market strategy
Tell us the device, where it is cleared and who you want to sell to. We will tell you what we would run first.
- 0115 minutes, video or phone
- 02A first-month plan
- 03A written next step after the call
Pick a day that suits · live availability
09/ questions
Medtech GTM FAQ
What device teams ask before a launch.
The plan that turns a cleared device into revenue: market order, beachhead segment, buying committee, evidence, channels and measures.
GTM is short for go-to-market.
Medtech GTM is the go-to-market work for medical technology companies, from launch planning to repeatable sales.
Commercialisation is the work of turning a device into a business: getting it to market, into the right providers and into repeat purchasing.
Yes.
The pathway decides when and where the device can be sold and what it may claim; your regulatory team owns that, and the go-to-market plan works within it.
One.
Win a beachhead segment with focused evidence and coverage, then use it as the reference for the next.
We start the motion on day one and build the system around it in weeks 1 to 4.
Taking on new clients
Medtech go-to-market one segment at a time
Fifteen minutes is enough to plan the first month.
11/ sources
Every source on this page
Each figure above links to one of these. All were opened and checked on 27 October 2026.
- FDA premarket approvalfda.gov
- 510(k)fda.gov
- De Novo pathwayfda.gov
- MHRA guidancegov.uk
- NHS Supply Chainsupplychain.nhs.uk
- NICE evidence standards frameworknice.org.uk
- Procurement Act 2023 became effective from 24 February 2025supplychain.nhs.uk
- MedTech Europe's 2025 figuresmedtecheurope.org